Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitors.
Xingxing HaoLouis D Falo IiiGuo ChenJiying ZhangCara D CareyWalter J StorkusLouis D FaloZhaoyang YouPublished in: Journal for immunotherapy of cancer (2021)
These data support the use of a novel genetic vaccine for the effective treatment of localized or multifocal melanoma refractory to conventional αPD1-based and/or Brafi-based (immune)therapy.